Neurizon Therapeutics (NUZTF) Stock Price, Quote, News & History

Q: What sector and industry does Neurizon Therapeutics (NUZTF) operate in?

Neurizon Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Comments

Neurizon Therapeutics (NUZTF) Stock Price, Quote, News & History

NUZTFOTCQB

Logo brought to you by Benzinga Data

Trade with Public

$0.0900

At close: Feb 2, 4:00 PM EST

Overview

Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

0 / 100.00

Day Range

- - -

52 Wk Range

0.07 - 0.12

Market Cap

$61.98M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.64

Recent Neurizon Therapeutics Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-21.55K

Financing Cash Flow (TTM)

8.76M

Free Cash Flow (TTM)

-14.29M

Capital Expenditure (TTM)

-1.55K

Net Change in Cash (TTM)

-5.55M

Valuation Metrics

Enterprise Value

$40.14M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

27.99

Earnings Yield % (TTM)

-29.16%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$4.16M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 100.00

Day Range

- - -

52 Wk Range

0.07 - 0.12

Market Cap

$61.98M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.64

About

Sector

Health Care

Industry

Pharmaceuticals

Neurizon Therapeutics Ltd is a clinical-stage biotech company that develops drug discovery intellectual property for the treatment of different types of neurodegenerative diseases. Its product pipeline is NUZ-001 (S-Monepantel).

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neurizon Therapeutics (NUZTF) stock?

You can purchase shares of Neurizon Therapeutics (OTCQB:NUZTF) through any online brokerage.

View our list of the best stock brokerages

Who are Neurizon Therapeutics (NUZTF) competitors?

There are no as such competitors for Neurizon Therapeutics.

What is the forecast, or price target, for Neurizon Therapeutics (NUZTF) stock?

There is no analysis for Neurizon Therapeutics to provide a consensus price target.

What is the current price for Neurizon Therapeutics (NUZTF)?

The stock price for Neurizon Therapeutics (OTCQB: NUZTF) is $0.09 last updated December 10, 2025 at 9:30 AM EST.

Does Neurizon Therapeutics (NUZTF) pay a dividend?

There are no upcoming dividends for Neurizon Therapeutics.

When is Neurizon Therapeutics (OTCQB:NUZTF) reporting earnings?

Neurizon Therapeutics does not have any upcoming earnings scheduled.

Is Neurizon Therapeutics (NUZTF) going to split?

There is no upcoming split for Neurizon Therapeutics.

What sector and industry does Neurizon Therapeutics (NUZTF) operate in?

Neurizon Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

Volume / Avg.

0 / 100.00

Day Range

- - -

52 Wk Range

0.07 - 0.12

Market Cap

$61.98M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.64

Recent Neurizon Therapeutics Ltd News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-21.55K

Financing Cash Flow (TTM)

8.76M

Free Cash Flow (TTM)

-14.29M

Capital Expenditure (TTM)

-1.55K

Net Change in Cash (TTM)

-5.55M

Valuation Metrics

Enterprise Value

$40.14M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

27.99

Earnings Yield % (TTM)

-29.16%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$0.00

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$4.16M

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

Volume / Avg.

0 / 100.00

Day Range

- - -

52 Wk Range

0.07 - 0.12

Market Cap

$61.98M

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

3.64

About

Sector

Health Care

Industry

Pharmaceuticals

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Neurizon Therapeutics (NUZTF) stock?

You can purchase shares of Neurizon Therapeutics (OTCQB:NUZTF) through any online brokerage.

View our list of the best stock brokerages

Who are Neurizon Therapeutics (NUZTF) competitors?

There are no as such competitors for Neurizon Therapeutics.

What is the forecast, or price target, for Neurizon Therapeutics (NUZTF) stock?

There is no analysis for Neurizon Therapeutics to provide a consensus price target.

What is the current price for Neurizon Therapeutics (NUZTF)?

The stock price for Neurizon Therapeutics (OTCQB: NUZTF) is $0.09 last updated December 10, 2025 at 9:30 AM EST.

Does Neurizon Therapeutics (NUZTF) pay a dividend?

There are no upcoming dividends for Neurizon Therapeutics.

When is Neurizon Therapeutics (OTCQB:NUZTF) reporting earnings?

Neurizon Therapeutics does not have any upcoming earnings scheduled.

Is Neurizon Therapeutics (NUZTF) going to split?

There is no upcoming split for Neurizon Therapeutics.

What sector and industry does Neurizon Therapeutics (NUZTF) operate in?

Neurizon Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCQB.